Prenatal and perinatal risk factors for neuroblastoma

被引:31
作者
Bluhm, Elizabeth [1 ,2 ]
McNeil, Dawn Elizabeth [3 ]
Cnattingius, Sven [4 ]
Gridley, Gloria [5 ]
El ghormli, Laure [6 ]
Fraumeni, Joseph F., Jr. [7 ]
机构
[1] Washington Hosp Ctr, Gen Internal Med Sect, Washington, DC 20010 USA
[2] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[3] US FDA, Div Neurol Drug Prod, Silver Spring, MD USA
[4] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[5] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[6] George Washington Univ, Ctr Biostat, Rockville, MD USA
[7] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
关键词
neuroblastoma; prenatal; delayed effects; prenatal exposure; anemia; case-control study;
D O I
10.1002/ijc.23847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuroblastoma is a rare embryonal tumor of childhood for which risk factors are not well known. Using a nested case-control design, we investigated prenatal, perinatal and neonatal risk factors in detail by linking 245 pediatric neuroblastoma cases identified in the Swedish Cancer Register diagnosed in the year 1973-1995 with the Swedish Medical Birth Register. Five living controls per case were randomly selected from the birth registry, matched by gender and age. Increased risks were associated with maternal anemia during pregnancy (odds ratio (OR) = 2.95, 95% confidence interval (CI): 1.53, 5.69), neonatal respiratory distress (OR = 3.61, 95% CI: 1.41, 9.24) and low (below or equal to 7) 1-min Apgar score (OR = 2.23, 95% CI: 1.41, 3.52). Increased risks were limited to cases diagnosed before 1 year of age. Markers of prenatal, perinatal and neonatal distress may be associated with neuroblastoma in infancy, but not with diagnoses at 1 year or above. Published 2008 Wiley-Liss, Inc.
引用
收藏
页码:2885 / 2890
页数:6
相关论文
共 56 条
[1]  
Adami J, 1996, INT J CANCER, V65, P774, DOI 10.1002/(SICI)1097-0215(19960315)65:6<774::AID-IJC11>3.0.CO
[2]  
2-4
[3]  
APGAR V, 1953, Curr Res Anesth Analg, V32, P260
[4]   Chromosome 1p and 11q deletions and outcome in neuroblastoma [J].
Attiyeh, EF ;
London, WB ;
Mossé, YP ;
Wang, Q ;
Winter, C ;
Khazi, D ;
McGrady, PW ;
Seeger, RC ;
Look, AT ;
Shimada, H ;
Brodeur, GM ;
Cohn, SL ;
Matthay, KK ;
Maris, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2243-2253
[5]   EPIDEMIOLOGY OF PRETERM BIRTH [J].
BERKOWITZ, GS ;
PAPIERNIK, E .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (02) :414-443
[6]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[7]  
BRODEUR GM, 2002, NEUROBLASTOMA
[8]  
Buck GM, 2001, PAEDIATR PERINAT EP, V15, P47
[9]   RELATION BETWEEN MATERNAL DIET AND SUBSEQUENT PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS IN YOUNG-CHILDREN [J].
BUNIN, GR ;
KUIJTEN, RR ;
BUCKLEY, JD ;
RORKE, LB ;
MEADOWS, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (08) :536-541
[10]   Maternal and perinatal characteristics in relation to neuroblastoma [J].
Chow, Eric J. ;
Friedman, Debra L. ;
Mueller, Beth A. .
CANCER, 2007, 109 (05) :983-992